caspofungin thij bot antifung caspofungin systemat iupac amino pneumocandin identifi number atc code pubchem drugbank chemic data formula mol mass gmol pharmacokinet data bioavail ivus onli protein bind metabol half life hour excret therapeut consider licenc data eu pregnanc cat legal statu prescript onli rout iv caspofungin inn brand cancida worldwid antifung drug class term echinocandin merck co activ infect aspergillu candida work inhibit enzym dglucan synthas therebi disturb integr fungal cell wall caspofungin administ intraven indic caspofungin acet inject wa origin approv fda emea europ current approv therapeut indic organ includ empir therapi presum fungal infect febril neutropen adult patient treatment invas aspergillosi adult patient diseas refractori intoler antifung agent ie convent lipid formul amphotericin andor itraconazol addit fda approv includ indic treatment candidemia specif candida infect intraabdomin abscess periton pleural caviti infect oesophag emea approv includ indic treatment gener invas candidiasi adult patient clinic efficaci patient refractori therapi respond well caspofungin therapi patient intoler therapi classifi respond direct compar studi drug treatment invas aspergillosi undertaken contraind hypersensit caspofungin acet ani ingredi formul warn hepat concomit caspofungin cyclosporin healthi volunt led frequent increas liver enzym altsgpt astsgot note cyclosporin alon combin treatment onli indic potenti benefit patient outweigh potenti risk dosag reduct patient moder impair liver function recommend clinic data exist regard caspofungin patient sever impair liver function sensit reaction reaction histamin releas rash facial swell pruritu sensat warmth case anaphylaxi reaction care watch drug resist patient infect caus albican mutant reduc sensit caspofungin notic current data regard develop resist fungi albican pregnanc lactat caspofungin ha anim studi embroyotox properti therefor ha assign class onli pregnant women benefit mother clearli outweigh poteni risk unborn drug milk lactat rat thi women lactat women treat cautious geriatr patient ordinarili dose adjust necessari pediatr patient suffici clinic experi judg safeti efficaci patient younger year age sideeffect compar amphotericin caspofungin rel low incid sideeffect clinic studi postmarket report sideeffect patient follow gastrointestin system nausea vomit abdomin pain diarrhea central nervou system headach bodi fever phlebiti thrombophleb complic intraven cannul site eg indur unspecifi pain flulikesyndrom myalgia chill paresthesia respiratori dyspnea renal increas plasma creatinin hematolog anemia electrolyt hypokalemia liver increas liver enzym asymptomat hypersensit rash facial edema pruritu tachycardia addit infrequ case symptomat liver damag peripher edema swell hypercalcemia case anaphylaxi sever allerg reaction ha note resist resist candida albican ha describ current rare mechan probabl point mutat synthas gene drug interact cyclosporin hepat tacrolimu potenti pharmacokinet interact system antimycot agent amphotericin itraconazol mycophenol interact induc drug clearanc eg carbamazepin phenytoin rifampin dexamethason consid iv mainten dose durat treatment durat therapi previou studi wa day patient heal treatment howev patient treat long day toler drug well indic longtim indic toler favour complic case aspergillosi gener durat treatment dictat sever diseas clinic respons improv immunecompet immunecompromis patient dosag initi dose ivinfus follow iv daili respons induc caspofungin clearanc abov coadminist daili dose increas iv infus approxim hour dosag form cancida ivinfus manufactur merck cancida ivinfus manufactur merck brand countri vari extern refer ahf databas cdc aspergillosi swiss pharmacompendium caspofungin cancidascom fda cancida emea cancida antifung ergosterol inhibitor azol inhibitor topic imidazol bifonazol clomidazol clotrimazol croconazol econazol fenticonazol ketoconazol isoconazol miconazol neticonazol oxiconazol sertaconazol sulconazol tioconazol triazol fluconazol fosfluconazol benzimidazol thiabendazol system triazol itraconazol posaconazol voriconazol polyen antimycot ergosterol bind topic natamycin nystatin system amphotericin allylamin squalen monooxygenas inhibitor topic amorolfin butenafin naftifin terbinafin system terbinafin synthas inhibitor echinocandin anidulafungin caspofungin micafungin intracellular pyrimidin analogu thymidyl synthas inhibitor flucytosin mitot inhibitor griseofulvin ciclopirox ethylparaben salicyl acid selenium sulfid tolnaft undecylen acid tea tree oil citronella oil lemon grass orang oil patchouli lemon myrtl whitfield ointment refer european medicin agenc list authoris medicin human baixench aoun desnosollivi al acquir resist echinocandin candida albican case report review journal antimicrobi chemotherapi doi pmid